Free Tools › JBI Critical Appraisal Checklists
Record JBI critical appraisal answers for randomized trials, cohort, analytical cross-sectional, case-control, prevalence, quasi-experimental, qualitative, case series, case report and systematic review studies, and download summary plots.
FreeNo account neededYour data stays in your browser
Answer the signalling questions in the official tool, then record your judgements here: JBI critical appraisal tools (jbi.global).
| Study | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Q12 | Q13 | Appraisal | Yes | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13/13 | ||||||||||||||||
| 11/13 | ||||||||||||||||
| 7/12 |
Your entries are saved in this browser only. Nothing is uploaded.
JBI checklists end with an overall decision (include, exclude or seek further information) made by the reviewers. Agree in advance how you will decide (for example, which items must be met) and apply it consistently. The yes count is shown for reference only.
The matching JBI checklist items appear.
Yes, no, unclear or not applicable, using the official checklist.
Include, exclude or seek further information, then download the plots.
JBI publishes critical appraisal checklists for most study designs used in evidence synthesis. Each item is answered yes, no, unclear or not applicable, and the reviewers then decide whether to include or exclude the study or seek further information.
JBI has revised several checklists as risk-of-bias tools: randomized controlled trials in 2023 (13 items), cohort studies in 2025 (11 items) and analytical cross-sectional studies in 2026 (8 items). The item topics here follow the current versions; the full questions and guidance are in the official checklists.
The checklists do not set one. Decide in advance how answers lead to inclusion or exclusion and apply the rule consistently.
Use the prevalence checklist for studies estimating how common a condition is, and the analytical cross-sectional checklist for studies of associations.